Previous study, revealed a relationship between the polymorphisms of the VEGF-pathway and clinical outcome of thyroid cancer which depends upon the clinical stage of the thyroid cancer [42], though the effect of VEGF in the angiogenesis of the tumor is vital, and is associated with effects with other angiogenic factors in late stages [28]. The gene discussed is VEGFA; the disease is neoplasm.